Strides Pharma Science Limited (STAR) — Cash Flow Reinvestment Rate
Strides Pharma Science Limited (STAR) has a Cash Flow Reinvestment Rate of 0.38x as of September 2025, reinvesting Rs1.49 Billion (capex Rs1.49 Billion ) from operating cash flow of Rs3.91 Billion. Check STAR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Strides Pharma Science Limited Cash Flow Reinvestment Rate (2005–2026)
Historical reinvestment intensity for Strides Pharma Science Limited across 20 annual periods. Explore STAR long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Strides Pharma Science Limited (2005–2026)
Year-by-year capital reinvestment analysis for Strides Pharma Science Limited. For live market cap and broader valuation context, see STAR stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.93x | Rs5.02 Billion | Rs5.39 Billion | Rs4.18 Billion | ▲ +92.0% |
| 2025 | 0.49x | Rs3.32 Billion | Rs6.84 Billion | Rs2.42 Billion | ▲ +26.8% |
| 2024 | 0.38x | Rs2.68 Billion | Rs7.01 Billion | Rs1.18 Billion | ▼ -95.7% |
| 2023 | 8.95x | Rs3.97 Billion | Rs444.11 Million | Rs949.38 Million | ▲ +694.3% |
| 2021 | 1.13x | Rs5.42 Billion | Rs4.81 Billion | Rs2.97 Billion | ▼ -24.7% |
| 2020 | 1.50x | Rs3.06 Billion | Rs2.05 Billion | Rs1.50 Billion | ▼ -81.2% |
| 2019 | 7.97x | Rs4.78 Billion | Rs600.55 Million | Rs3.29 Billion | ▲ +38.6% |
| 2018 | 5.75x | Rs10.75 Billion | Rs1.87 Billion | Rs4.03 Billion | ▲ +100.7% |
| 2017 | 2.86x | Rs8.25 Billion | Rs2.88 Billion | Rs6.82 Billion | ▼ -91.2% |
| 2016 | 32.68x | Rs23.42 Billion | Rs716.57 Million | Rs22.95 Billion | ▲ +270.6% |
| 2015 | 8.82x | Rs7.35 Billion | Rs834.00 Million | Rs2.42 Billion | ▲ +250.9% |
| 2013 | 2.51x | Rs3.38 Billion | Rs1.34 Billion | Rs3.38 Billion | ▲ +380.3% |
| 2012 | 0.52x | Rs2.39 Billion | Rs4.57 Billion | Rs2.39 Billion | ▲ +1.7% |
| 2011 | 0.51x | Rs1.67 Billion | Rs3.24 Billion | Rs1.67 Billion | ▼ -74.9% |
| 2010 | 2.05x | Rs1.31 Billion | Rs638.65 Million | Rs1.31 Billion | ▼ -20.2% |
| 2009 | 2.57x | Rs3.03 Billion | Rs1.18 Billion | Rs3.03 Billion | ▲ +1.0% |
| 2008 | 2.55x | Rs2.51 Billion | Rs987.01 Million | Rs2.51 Billion | ▲ +73.3% |
| 2007 | 1.47x | Rs1.58 Billion | Rs1.08 Billion | Rs1.58 Billion | ▼ -20.8% |
| 2006 | 1.85x | Rs1.47 Billion | Rs790.26 Million | Rs1.47 Billion | ▲ +74.3% |
| 2005 | 1.06x | Rs796.99 Million | Rs749.22 Million | Rs796.99 Million | — |